MedPath

EmpowerPharm Inc

πŸ‡¨πŸ‡¦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 2
1 (100.0%)

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

Phase 2
Completed
Conditions
Social Anxiety Disorder
Interventions
First Posted Date
2022-10-31
Last Posted Date
2024-11-21
Lead Sponsor
EmpowerPharm Inc.
Target Recruit Count
239
Registration Number
NCT05600114
Locations
πŸ‡ΊπŸ‡Έ

EPI-CBD-001 Site, Bellevue, Washington, United States

πŸ‡ΊπŸ‡Έ

EPI-CBD-001-Site, Rochester, New York, United States

πŸ‡ΊπŸ‡Έ

EPI-CBD-001 site, Wichita Falls, Texas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.